Ciron Drugs And Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Mumbai City, Maharashtra, India, established in 1990.
1990 Mumbai City, Maharashtra, India Active
Last Updated:
Access Report
About Ciron Drugs And Pharmaceuticals Private Limited

Ciron Drugs And Pharmaceuticals Private Limited, a active private limited company, was established on 04 June 1990 in Mumbai City, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24246MH1990PTC056735. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹8.30 M.

It upholds a compliant status. Its leadership includes Keyur Ratanshi Shah (Managing Director), Biswajit Paul (Director), Madan Trimbak Hiwale (Director). Past directors included Keyur Ratanshi Shah, Rahul Gangadhar Sankhe, Biswajit Paul. It holds ₹21.16 Cr open charges and ₹125.51 Cr settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at C- 1101/02, Lotus Corporate Park Goregaon(East), Mumbai-400063, Mumbai City, Maharashtra, 400063.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24246MH1990PTC056735

  • Registration Number

    056735

  • Incorporation Date

    04 June 1990

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹8.30 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 8.30 M
  • Company Age 35 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 21.16 Cr
  • Satisfied Charges ₹ 125.51 Cr
  • Revenue Growth **** 14.61%
  • Profit Growth **** 28.87%
  • Ebitda **** 32.81%
  • Net Worth 3.06%
  • Total Assets **** 5.94%
Company report

Ciron Drugs And Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ciron Drugs And Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ciron Drugs And Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Keyur Ratanshi Shah Managing Director 15 Feb 2016 Current
Biswajit Paul Director 12 May 2021 Current
Madan Trimbak Hiwale Director 12 May 2021 Current
Kirti Talakshi Shah Director 18 Jun 2005 Current
Samir Ratanshi Shah Director 10 Jul 2000 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 06 Feb 2025 Past
Pramod Abcsdd Manager - Past
Pramod Abcsdd Additional Director 12 Nov 2021 Past
Pramod Abcsdd Additional Director 12 Nov 2021 Past
Pramod Abcsdd Director 05 Feb 2020 Past
Pramod Abcsdd Director 05 Feb 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ciron Drugs And Pharmaceuticals.

Ciron Drugs And Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 14.61% increase. The company also saw a substantial improvement in profitability, with a 28.87% increase in profit. The company's net worth moved up by a moderate rise of 3.06%.

Ciron Drugs And Pharmaceuticals revenue growth over time
Ciron Drugs And Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 14.61%
*******
*******
*******
*******
Revenue from Operations
*******
 16.91%
*******
*******
*******
*******
Total Assets
*******
 5.94%
*******
*******
*******
*******
Profit or Loss
*******
 28.87%
*******
*******
*******
*******
Net Worth
*******
 3.06%
*******
*******
*******
*******
EBITDA
*******
 32.81%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ciron Drugs And Pharmaceuticals?

In 2024, Ciron Drugs And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹211,573,308.82

Satisfied Charges

₹1,255,125,000.00

Charges Breakdown by Lending Institutions
  • Others : 10.30 Cr
  • Citi Bank N.A. : 10.00 Cr
  • The Saraswat Co-Op. Bank Ltd : 0.83 Cr
  • Citi Bank : 0.02 Cr
Latest Charge Details
Date Lender Amount Status
29 Oct 2021 Others ₹10.00 Cr Open
17 Feb 2020 Others ₹3.04 M Open
25 Jul 2018 Citi Bank N.A. ₹10.00 Cr Open
07 Oct 1997 Citi Bank ₹0.23 M Open
02 Nov 1994 The Saraswat Co-Op. Bank Ltd ₹4.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Ciron Drugs And Pharmaceuticals?

Unlock and access historical data on people associated with Ciron Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ciron Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ciron Drugs And Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ciron Drugs And Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Keyur Ratanshi Shah was appointed as a Ceo was appointed as a Ceo on 18 Apr 2025 & has been associated with this company since 10 months 21 days . was recorded as a recent event.

  • Annual General Meeting

    Progress on Ciron Drugs And Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Ciron Drugs And Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.

  • Charges

    Progress on A charge registered on 08 Mar 2018 via Charge ID 100181991 with Yes Bank Limited was fully satisfied on 20 Dec 2022. was documented.

  • Charges

    The activity A charge registered on 22 Aug 2012 via Charge ID 10374461 with Yes Bank Limited was fully satisfied on 20 Dec 2022. was completed.

  • Charges

    The activity A charge registered on 11 Jan 2019 via Charge ID 100242311 with Axis Bank Limited was fully satisfied on 03 Feb 2022. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ciron Drugs And Pharmaceuticals Private Limited?

The CIN of Ciron Drugs And Pharmaceuticals Private Limited is U24246MH1990PTC056735.

Where is Ciron Drugs And Pharmaceuticals Private Limited headquartered?

Ciron Drugs And Pharmaceuticals Private Limited is headquartered at C- 1101/02, Lotus Corporate Park Goregaon(East), Mumbai-400063, Mumbai City, Maharashtra, 400063.

When was Ciron Drugs And Pharmaceuticals Private Limited incorporated?

Ciron Drugs And Pharmaceuticals Private Limited was incorporated on 04 June 1990.

Who are the current directors of Ciron Drugs And Pharmaceuticals Private Limited?

The current directors of Ciron Drugs And Pharmaceuticals Private Limited are

What is the primary industry of Ciron Drugs And Pharmaceuticals Private Limited?

The primary industry of Ciron Drugs And Pharmaceuticals Private Limited is Manufacturing.

Is Ciron Drugs And Pharmaceuticals Private Limited a listed company?

Ciron Drugs And Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Ciron Drugs And Pharmaceuticals Private Limited?

The authorized capital of Ciron Drugs And Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹8.30 M.

What is the compliance status of Ciron Drugs And Pharmaceuticals Private Limited?

The compliance status of Ciron Drugs And Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available